Monocytes engineered with iSNAP inhibit human B-lymphoma progression.
Saved in:
| Title: | Monocytes engineered with iSNAP inhibit human B-lymphoma progression. |
|---|---|
| Authors: | Wu H; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.; Institute of Clinical Medicine, Stem Cell Research Center National Yang Ming University Taipei Taiwan., Amirfakhri S; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA., Lin HH; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA., Hollandsworth H; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA., Filemoni F; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA., Liu Y; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA., Wu Y; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA., Li JYS; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA., Xu H; Department of Statistics University of California Los Angeles California USA., Chien S; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.; Department of Medicine University of California San Diego San Diego California USA., Bouvet M; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA., Wang Y; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA. |
| Source: | Bioengineering & translational medicine [Bioeng Transl Med] 2022 Jan 12; Vol. 7 (2), pp. e10285. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101689146 Publication Model: eCollection Cited Medium: Print ISSN: 2380-6761 (Print) Linking ISSN: 23806761 NLM ISO Abbreviation: Bioeng Transl Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35600645 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Monocytes engineered with iSNAP inhibit human B-lymphoma progression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.; Institute of Clinical Medicine, Stem Cell Research Center National Yang Ming University Taipei Taiwan.<br /><searchLink fieldCode="AU" term="%22Amirfakhri+S%22">Amirfakhri S</searchLink>; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Lin+HH%22">Lin HH</searchLink>; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Hollandsworth+H%22">Hollandsworth H</searchLink>; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Filemoni+F%22">Filemoni F</searchLink>; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Wu+Y%22">Wu Y</searchLink>; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Li+JYS%22">Li JYS</searchLink>; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Department of Statistics University of California Los Angeles California USA.<br /><searchLink fieldCode="AU" term="%22Chien+S%22">Chien S</searchLink>; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA.; Department of Medicine University of California San Diego San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Bouvet+M%22">Bouvet M</searchLink>; Department of Surgery, Moores Cancer Center University of California, San Diego San Diego California USA.; Department of Surgery VA San Diego Healthcare System San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Bioengineering and Institute of Engineering in Medicine University of California San Diego San Diego California USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101689146%22">Bioengineering & translational medicine</searchLink> [Bioeng Transl Med] 2022 Jan 12; Vol. 7 (2), pp. e10285. <i>Date of Electronic Publication: </i>2022 Jan 12 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Inc%22">John Wiley & Sons Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101689146 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2380-6761 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223806761%22">23806761 </searchLink><i>NLM ISO Abbreviation: </i>Bioeng Transl Med <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35600645 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/btm2.10285 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e10285 Titles: – TitleFull: Monocytes engineered with iSNAP inhibit human B-lymphoma progression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu H – PersonEntity: Name: NameFull: Amirfakhri S – PersonEntity: Name: NameFull: Lin HH – PersonEntity: Name: NameFull: Hollandsworth H – PersonEntity: Name: NameFull: Filemoni F – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Wu Y – PersonEntity: Name: NameFull: Li JYS – PersonEntity: Name: NameFull: Xu H – PersonEntity: Name: NameFull: Chien S – PersonEntity: Name: NameFull: Bouvet M – PersonEntity: Name: NameFull: Wang Y IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 01 Text: 2022 Jan 12 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2380-6761 Numbering: – Type: volume Value: 7 – Type: issue Value: 2 Titles: – TitleFull: Bioengineering & translational medicine Type: main |
| ResultId | 1 |